Advanced search
Publication Cover
Cancer Investigation Volume 27, 2009 - Issue 9
Submit an article Journal homepage
155
Views
22
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLECellular and Molecular Biology

The Impacts of ERCC1 Gene Exon VIII Alternative Splicing on Cisplatin-Resistance in Ovarian Cancer Cells

Yehong Sun
,
Tiyuan LiThe Second Medical College, Jinan University, Shenzhen Clinical Medical Research Center, Shenzhen People's Hospital, Shenzhen 518020, Guangdong, P.R. China.
,
Kewei MaDepartment of Hemotology and Oncology, The First Hospital, Jilin University, Changchun 130021, P.R. China.
,
Zhongkai TianThe Second Medical College, Jinan University, Shenzhen Clinical Medical Research Center, Shenzhen People's Hospital, Shenzhen 518020, Guangdong, P.R. China.
,
Ying ZhuThe Second Medical College, Jinan University, Shenzhen Clinical Medical Research Center, Shenzhen People's Hospital, Shenzhen 518020, Guangdong, P.R. China.
,
Fuqiang ChenThe Second Medical College, Jinan University, Shenzhen Clinical Medical Research Center, Shenzhen People's Hospital, Shenzhen 518020, Guangdong, P.R. China.
&
Gang HuDepartment of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
 show all
Pages 891-897 | Published online: 15 Oct 2009

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Luc Friboulet, Sophie Postel-Vinay, Tony Sourisseau, Julien Adam, Annabelle Stoclin, Florence Ponsonnailles, Nicolas Dorvault, Frédéric Commo, Patrick Saulnier, Sophie Salome-Desmoulez, Géraldine Pottier, Fabrice André, Guido Kroemer, Jean Charles Soria & Ken André Olaussen. (2013) ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform. Cell Cycle 12:20, pages 3298-3306.
Read now

Articles from other publishers (21)

Xinxin Meng, Fengyun Ma & Dingli Yu. (2024) The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles. Environmental Research 240, pages 117362.
Crossref
Shivani Tendulkar & Suneel Dodamani. (2021) Chemoresistance in Ovarian Cancer: Prospects for New Drugs. Anti-Cancer Agents in Medicinal Chemistry 21:6, pages 668-678.
Crossref
Ilenia Pellarin, Barbara Belletti & Gustavo Baldassarre. (2020) RNA splicing alteration in the response to platinum chemotherapy in ovarian cancer: A possible biomarker and therapeutic target. Medicinal Research Reviews 41:1, pages 586-615.
Crossref
Anja Charlotte Lundgren Mortensen, Tabassom Mohajershojai, Mehran Hariri, Marika Pettersson & Diana Spiegelberg. (2020) Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib. Frontiers in Oncology 10.
Crossref
Chen-Xue Mao, Min Li, Wei Zhang, Hong-Hao Zhou, Ji-Ye Yin & Zhao-Qian Liu. (2020) Pharmacogenomics for the efficacy of platinum-based chemotherapy: Old drugs, new integrated perspective. Biomedicine & Pharmacotherapy 126, pages 110057.
Crossref
Ilenia Pellarin, Alessandra Dall’Acqua, Alice Gambelli, Ilenia Pellizzari, Sara D’Andrea, Maura Sonego, Ilaria Lorenzon, Monica Schiappacassi, Barbara Belletti & Gustavo Baldassarre. (2020) Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity. Oncogene 39:22, pages 4390-4403.
Crossref
Tianshui Sun & Qing Yang. (2020) Chemoresistance‑associated alternative splicing signatures in serous ovarian cancer. Oncology Letters.
Crossref
Yin-Wei Cheng, Yun-Mei Chen, Qian-Qian Zhao, Xing Zhao, Ya-Ru Wu, Dan-Ze Chen, Lian-Di Liao, Yang Chen, Qian Yang, Li-Yan Xu, En-Min Li & Jian-Zhen Xu. (2019) Long Read Single-Molecule Real-Time Sequencing Elucidates Transcriptome-Wide Heterogeneity and Complexity in Esophageal Squamous Cells. Frontiers in Genetics 10.
Crossref
Lin Yang, Wenjie Wei, Lei Zhou, Jing Wang & Guangyuan Hu. (2019) High/positive expression of ERCC1 predicts poor treatment response and survival prognosis in nasopharyngeal carcinoma. Medicine 98:21, pages e15641.
Crossref
Jia Liu, Lin Zhang, Ping Mao, Guoqiang Jiang, Likun Liu, Jing Wang, Wei Yang, Lawrence Owusu & Weiling Li. (2017) Functional characterization of a novel transcript of ERCC1 in chemotherapy resistance of ovarian cancer. Oncotarget 8:49, pages 85759-85771.
Crossref
V. Formica, E. Doldo, F.R. Antonetti, A. Nardecchia, P. Ferroni, S. Riondino, C. Morelli, H.T. Arkenau, F. Guadagni, A. Orlandi & M. Roselli. (2017) Biological and predictive role of ERCC1 polymorphisms in cancer. Critical Reviews in Oncology/Hematology 111, pages 133-143.
Crossref
Lulzim Shkreta & Benoit Chabot. (2015) The RNA Splicing Response to DNA Damage. Biomolecules 5:4, pages 2935-2977.
Crossref
Lilan Chen, Ting Liu, Jinhua Zhou, Yunfei Wang, Xinran Wang, Wen Di & Shu Zhang. (2014) Citrate Synthase Expression Affects Tumor Phenotype and Drug Resistance in Human Ovarian Carcinoma. PLoS ONE 9:12, pages e115708.
Crossref
S Postel-Vinay, I Bajrami, L Friboulet, R Elliott, Y Fontebasso, N Dorvault, K A Olaussen, F André, J-C Soria, C J Lord & A Ashworth. (2013) A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer. Oncogene 32:47, pages 5377-5387.
Crossref
Laurie A. Heinicke, Behnam Nabet, Shihao Shen, Peng Jiang, Sebastiaan van Zalen, Benjamin Cieply, J. Eric Russell, Yi Xing & Russ P. Carstens. (2013) The RNA Binding Protein RBM38 (RNPC1) Regulates Splicing during Late Erythroid Differentiation. PLoS ONE 8:10, pages e78031.
Crossref
Luc Friboulet, Ken André Olaussen, Jean-Pierre Pignon, Frances A. Shepherd, Ming-Sound Tsao, Stephen Graziano, Robert Kratzke, Jean-Yves Douillard, Lesley Seymour, Robert Pirker, Martin Filipits, Fabrice André, Eric Solary, Florence Ponsonnailles, Angélique Robin, Annabelle Stoclin, Nicolas Dorvault, Frédéric Commo, Julien Adam, Elsa Vanhecke, Patrick Saulnier, Jürgen Thomale, Thierry Le Chevalier, Ariane Dunant, Vanessa Rousseau, Gwénaël Le Teuff, Elisabeth Brambilla & Jean-Charles Soria. (2013) ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer. New England Journal of Medicine 368:12, pages 1101-1110.
Crossref
Benjamin BesseKen A. OlaussenJean-Charles Soria. (2013) ERCC1 and RRM1: Ready for Prime Time?. Journal of Clinical Oncology 31:8, pages 1050-1060.
Crossref
Vassiliki Kotoula, Dimitrios Krikelis, Vasilios Karavasilis, Triantafillia Koletsa, Anastasia G Eleftheraki, Despina Televantou, Christos Christodoulou, Stefanos Dimoudis, Ippokratis Korantzis, Dimitrios Pectasides, Konstantinos N Syrigos, Paris A Kosmidis & George Fountzilas. (2012) Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS). BMC Cancer 12:1.
Crossref
Luc Friboulet, Daniel Barrios-Gonzales, Frédéric Commo, Ken André Olaussen, Stephan Vagner, Julien Adam, Aïcha Goubar, Nicolas Dorvault, Vladimir Lazar, Bastien Job, Benjamin Besse, Pierre Validire, Philippe Girard, Ludovic Lacroix, Johanna Hasmats, Fabienne Dufour, Fabrice André & Jean-Charles Soria. (2011) Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC. Clinical Cancer Research 17:17, pages 5562-5572.
Crossref
Ken André Olaussen, David Planchard, Julien Adam & Jean-Charles Soria. (2011) Voies de réparation de l’ADN et cancers bronchiques non à petites cellules : perspectives cliniques. Bulletin du Cancer 98:3, pages 305-322.
Crossref
Alakananda Basu & Soumya Krishnamurthy. (2010) Cellular Responses to Cisplatin-Induced DNA Damage. Journal of Nucleic Acids 2010, pages 1-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.